Sponsors (30)
The bill expands and standardizes veterans' access to FDA‑approved non‑opioid postoperative pain treatments—potentially reducing opioid harms—but risks higher VA/taxpayer costs, shifted funding away from toxic exposure care, and administrative strain from rapid implementation deadlines.
Veterans will get faster access to FDA‑approved non‑opioid postoperative pain treatments, expanding pain‑management options and likely reducing opioid use and related harms (addiction, overdose).
VA hospitals and veterans will see more standardized prescribing and procurement of these non‑opioid products across facilities, simplifying care delivery and improving consistency of postoperative pain management.
Veterans who receive toxic exposure care and other VA beneficiaries could face reduced resources because the bill prohibits using the Cost of War Toxic Exposures Fund for implementation, shifting costs onto other VA budgets.
Taxpayers and the VA medical system may see higher drug procurement and program costs if the VA must add these drugs to the formulary within the mandated timelines.
The Secretary of Veterans Affairs and VA facilities may face administrative strain from the 90‑day implementation deadline, risking rushed evaluations or procurement decisions.
Based on analysis of 2 sections of legislative text.
Requires VA to add FDA-approved non-opioid postoperative/regional analgesic drugs/biologics to its national formulary and standardization list within set timelines and forbids using the Cost of War Toxic Exposures Fund for implementation.
Introduced July 17, 2025 by Greg Landsman · Last progress July 17, 2025
Requires the Department of Veterans Affairs to add FDA-approved or authorized non-opioid drugs and biological products that reduce postoperative pain or provide postsurgical/regional analgesia (and that do not act on opioid receptors) to the VA National Formulary and the VA drug standardization list. The VA must add eligible products within one year after they become eligible for certain Medicare payments; the Secretary must implement the statutory changes within 90 days of enactment and may not use the Cost of War Toxic Exposures Fund to pay for implementation.